Share:
Tenofovir alafenamide (TAF) could be used as once-weekly oral PrEP, an animal study conducted by the US Centers for Disease Control suggests.
Options for non-daily PrEP are limited, due to the lack of agents that persist in the body long enough to permit weekly or monthly dosing.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
[CROI 2026] HIV i-Base: Only three new HIV cases on lenacapavir PrEP: updates from PURPOSE-1 and -2
-
aidsmap: DoxyPEP halves overall syphilis cases, with possible indirect benefits for women
-
[Press release] US and Global Fund expand commitment to long-acting HIV prevention as country rollout of lenacapavir accelerates
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.